Detalles del proyecto
| Estado | Finalizado |
|---|---|
| Fecha de inicio/Fecha fin | 9/21/10 → 8/31/12 |
Financiación
- EMD Serono Incorporated: 52.737,00 US$
A Phase II, Open-Label, 1:1 Randomized, Controlled Trial Exploring the Efficacy of EMD 1201081 in Combination with Cetuximab in Second-Line Cetuximab-Naive Subjects with Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck
- Arnold, Susanne M (PI)